Keywords:
Oxytocin; Obesity; Non-alcoholic fatty liver disease; Hepatic steatosis; Biomarkers.References
Aßfalg A, Lucht MJ, Schulte-Herbrüggen O, Köpp W, Grön G, Hallschmid M, et al. Lower oxytocin levels are associated with higher body mass index and greater eating disorder psychopathology in obese patients. Obes Facts. 2018;11(5):440–452. doi:10.1159/000492130
Beranger GE, Pisani DF, Castel J, Djedaini M, Battaglia S, Amiaud J, et al. Oxytocin reverses high-fat diet-induced obesity in mice by targeting adipocyte precursors. Nat Commun. 2022;13:2139. doi:10.1038/s41467-022-29828-5
Blevins JE, Ho JM. Role of oxytocin signaling in the regulation of body weight. Rev Endocr Metab Disord. 2013;14(4):311–329. doi:10.1007/s11154-013-9256-8
Düşünceli F, Işeri SO, Ercan F, Gedik N, Yeğen BC. Oxytocin alleviates oxidative injury in colitis by a neutrophil-dependent mechanism. Peptides. 2008;29(3):621–626. doi:10.1016/j. peptides.2007.12.013
Gajdošechová L, Kršková K, Olszanecki R, Zorad Š, Olszanecka-Glinianowicz M, Železníková V, et al. Hypothalamic oxytocin gene expression is reduced in rats with diet-induced obesity. Endocr Regul. 2014;48(4):171–179. doi:10.4149/endo_2014_04_171
Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673–689. doi:10.1007/s40273-014-0243-x
Klement J, Ott V, Rapp K, Brede S, Hallschmid M, Lehnert H, et al. Oxytocin levels are reduced in obesity and type 2 diabetes. Obesity (Silver Spring). 2023;31(1):35–44. doi:10.1002/ oby.23581
Lawson EA, Olszewski PK, Weller A, Blevins JE. The role of oxytocin in regulation of appetite and metabolism: empirical findings and conceptual considerations. Physiol Behav. 2015;152:456–467. doi:10.1016/j.physbeh.2015.06.024
Leng G, Sabatier N. Oxytocin—the sweet hormone? Trends Endocrinol Metab. 2017;28(5):365–376. doi:10.1016/j.tem.2017.02.007
McCormack SE, Blevins JE, Lawson EA. Metabolic effects of oxytocin. Endocr Rev. 2019;40(4):1218–1244. doi:10.1210/er.2018-00277
Mohey A, Mohamed A, Rashwan HM, Abdel-Rahman RF, Khalaf MM, Fathy M, et al. Oxytocin attenuates hepatic injury and oxidative stress in experimental cholestasis. Clin Exp Pharmacol Physiol. 2022;49(3):339–347. doi:10.1111/1440-1681.13593
NCD Risk Factor Collaboration (NCD-RisC). Country profile: Uzbekistan [Internet]. 2024 [cited 2025 Aug 8]. Available from: https://ncdrisc.org
Ott V, Finlayson G, Lehnert H, Heitmann B, Heinrichs M, Born J, et al. Oxytocin reduces reward-driven food intake in humans. Diabetes. 2013;62(10):3418–3425. doi:10.2337/db13-0665
Plante E, Mena-Morales A, Olivo G, Balderas C, Vetrani C, Godos J, et al. Association between oxytocin, eating behavior, and metabolic health in humans: a systematic review. Nutrients. 2022;14(15):3094. doi:10.3390/nu14153094
Saad MA, El-Dayem SMA, Abdel-Dayem MA, Abdel-Moneim A, Abdel-Rahman RF, Abdel-Latif HA, et al. Oxytocin ameliorates metabolic derangements in high-fat diet-induced obesity in rats. Can J Physiol Pharmacol. 2018;96(6):664–671. doi:10.1139/cjpp-2017-0385
Wang Y, Wang X, Guo C, Zhang H, Zhang Z, Liu F, et al. Plasma oxytocin is reduced in patients with advanced nonalcoholic fatty liver disease. Front Endocrinol (Lausanne). 2021; 12: 753227. doi:10.3389/fendo.2021.753227
World Health Organization. Obesity and overweight [Internet]. Geneva: WHO; 2023 [cited 2025 Aug 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Yamasue H, Yee JR, Hurlemann R, Rilling JK, Chen FS, Meyer-Lindenberg A, et al. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci. 2012;32(41):14109–14117. doi:10.1523/ JNEUROSCI.3327-12.2012
Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801. doi:10.1016/j.jhep.2019.06.021
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431
Zhai Q, Luo Y, Yang W, Li X, Zhang X, Chen Y, et al. Oxytocin ameliorates liver fibrosis via inhibition of macrophage-mediated inflammation. Biomed Pharmacother. 2024;167:115638. doi:10.1016/j.biopha.2023.115638
Zhang H, Wu C, Chen Q, Li L, Xu Z, Zhao Y, et al. Oxytocin attenuates hepatic lipid accumulation through activation of AMPK. J Endocrinol Invest. 2021;44(8):1723–1733. doi:10.1007/s40618-021-01506-3